Lynx.MD

🚨 Exciting news! 🚨 We’re proud to have supported our partners' successful poster presentation at the American Rhinologic Society (ARS) 2024 Symposium! This collaboration highlights our commitment to advancing research in rhinology and enabling impactful healthcare solutions through data-driven insights. Check out the full article to learn more about how Lynx.MD is helping drive innovation in healthcare! #HealthcareInnovation #Rhinology #ARS2024 #DataDrivenResearch #LynxMD #MedicalResearch

🚨 Exciting news! 🚨 We’re proud to have supported our partners' successful poster presentation at the American Rhinologic Society (ARS) 2024 Symposium! This collaboration highlights our commitment to advancing research in rhinology and enabling impactful healthcare solutions through data-driven insights. Check out the full article to learn more about how Lynx.MD is helping drive innovation in healthcare! #HealthcareInnovation #Rhinology #ARS2024 #DataDrivenResearch #LynxMD #MedicalResearch

🍂 As we transition into Fall, it's not just Football, Pumpkin Spice, and cooler temps; it's about discovery and innovation in Life Sciences and MedTech. 🧬 The Lynx.MD team will be at #MedTechX, #ARS 2024, and #DIA RWD to explore the latest research shaping the future of drug development and market access. Read more about what we are looking forward to: https://lnkd.in/gxai2JW7 Reach out to Collin Labar to meet up at one of these industry events for a coffee and data-driven conversation. ☕🚀 #LifeSciences #MedTech #RealWorldData #AI

🔭 Looking forward to ARS 70th Annual Meeting, September 27-28! 🌴 Lynx.MD we will be very interested in poster #A002: "A Descriptive Analysis of Characteristics of CRSwNP Patients Within US Clinical Practice," co-authored by Joseph K. Han, MD. 🩺 #ARS70 #CRSwNP #HealthcareResearch #RWD ARS 70 Agenda: https://lnkd.in/gErEAsXm

🔍 At first glance, #Gastroenterology, #Dermatology, and #ENT #Allergy might seem unrelated. Yet, they share a common thread: excessive type 2 inflammation. This overactive immune response can drive diverse conditions, from asthma and eczema to chronic rhinosinusitis and eosinophilic esophagitis. Robert Eisdorfer, MD explains the impact of type 2 inflammation on these diseases. And looks at how real-world data can impact research. Read now: https://lnkd.in/gh_xwP6z #HealthInnovation #DataDrivenMedicine #LynxMD Robert Eisdorfer, MD Collin Labar Omer Dror

Lynx.MD is hiring! Connect, via LinkedIn, with our team of data scientists, cybersecurity and healthcare experts to learn more about our amazing company! https://lnkd.in/g99mksgX

🚀 Israel’s top healthcare 🏥 organizations are leveraging real-world data to drive innovation that will improve patient care. Kineret Data Innovation and Clalit Innovation show how secure data sharing can accelerate research, inform better treatment decisions, and drive impactful healthcare outcomes. Healthcare organizations worldwide 🌐 can learn from these strategies to enhance their own data-driven innovation. 📊 🔗 Read More https://lnkd.in/gg7577P5 #HealthcareInnovation #RealWorldData #MedicalResearch #DataIntelligence

🔬Life Sciences and MedTech companies face a critical challenge: understanding the real-world impact of therapeutics on patients after market entry. 💡 Lynx.MD is bridging the gap between healthcare partners and Life Sciences/MedTech innovators to bring real-world longitudinal data that delivers the insights you need now to understand patient outcomes. 📊🤝 Ready to explore the future of healthcare? Swipe through our infographic to preview the data assets we bring to innovation. 🚀 👉 Contact our team on LinkedIn today, Collin Labar, Robert Eisdorfer, MD, @Jody Bare. https://lynx.md/ #RealWorldData #LifeSciences #MedTech #HealthcareInnovation #PatientOutcomes #LynxMD

🚀 New Blog Alert! 🚀 Lynx.MD's Collin Labar looks at The Role of Technology and Real-World Data in Advancing MASH Treatment. We dive into the crucial role RWD can play in post-market surveillance. 🔎 Discover how RWD can enhance our understanding of new #MASH treatments, monitor patient outcomes, and refine therapy effectiveness beyond clinical trials. 👉 Read more: https://lnkd.in/gj45ZBzv #Healthcare #MASH #RealWorldData #PostMarketSurveillance #Gastroenterology #Rezdiffra #MadrigalPharmaceuticals Omer Dror Robert Eisdorfer, MD

In this week's round-up from The Evidence Base®: Read our summary of the third session of the #GetRealConference2024, which debated the progress towards adopting #RWE as part of the #HTA regulation. The debate was moderated by Shahid Hanif (Managing Director, GetReal Institute). Speaking for the motion was Iñaki Gutiérrez-Ibarluzea (BIOEF, Spain) and Juan Carlos Rejón-Parrilla (AETS, Spain), while Inka Heikkinen (MSD, Denmark) and Anke van Engen (IQVIA, The Netherlands) argued against the motion. Read our summary of session 4 of the #GetRealConference2024, which explored HTA perspectives on methods for generating #realworldevidence We share the first look at the #ISPOREurope2024 conference program See our pick of #RWE articles published in July 2024 Don't forget to sign up to our #webinars, details inside: - Replacing serum with dried blood #microsampling for #pediatric pharmacokinetics of prophylactic RSV monoclonal antibody, September 25, 2024, 11:00am ET - Introducing the ROPAD consortium: unlocking real-world #genetic insights to accelerate treatment access for #Parkinson’s disease, September 24, 2024, 10:30am ET Plus, new articles from the Journal of Comparative Effectiveness Research, and #rwe and #rwd news from Lynx.MD and Schweiger Dermatology Group, the European Medicines Agency, and Truveta